Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 9, 2017
Histone H3.3 regulates mitotic progression in mouse embryonic fibroblastsAysegul Ors, Christophe Papin, Bertrand Favier, et al.Anti-Cancer Drugs|March 12, 2010
Paclitaxel is effective in relapsed head and neck squamous cell carcinoma: a retrospective study of 66 patients at a single institutionJérôme Fayette, Anthony Montella, Sylvie Chabaud, et al.Bulletin Du Cancer|January 20, 2012
First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancerJulien Peron, Olivier Tredan, Isabelle Ray-Coquard, et al.Life Science Alliance|January 13, 2022
Identification of human gene research articles with wrongly identified nucleotide sequencesYasunori Park, Rachael A West, Pranujan Pathmendra, et al.Hematological Oncology|April 3, 2008
Combination of rituximab with chemotherapy in diffuse large B-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indicationHervé Ghesquières, Céline Ferlay, Catherine Sebban, et al.Cell Cycle (Georgetown, Tex.)|February 18, 2009
Benzo[e]pyridoindoles, novel inhibitors of the aurora kinasesThi My-Nhung Hoang, Bertrand Favier, Annie Valette, et al.Anti-Cancer Drugs|May 31, 2012
Paclitaxel and cetuximab combination efficiency after the failure of a platinum-based chemotherapy in recurrent/metastatic head and neck squamous cell carcinomaJulien Péron, Philippe Ceruse, Emilie Lavergne, et al.Cellular Microbiology|November 10, 2007
Activation of classical pathway of complement cascade by soluble oligomers of prionChantal Dumestre-Pérard, Joseph Osmundson, Catherine Lemaire-Vieille, et al.Clinical Breast Cancer|May 13, 2009
Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case seriesSana Intidhar Labidi, Thomas Bachelot, Isabelle Ray-Coquard, et al.European Journal of Cancer (Oxford, England : 1990)|February 1, 2024
Early morning immune checkpoint blockade and overall survival of patients with metastatic cancer: An In-depth chronotherapeutic studySimona Catozzi, Souad Assaad, Lidia Delrieu, et al.Pageof 5